• cymabay therapeutics, inc. announces presentations at the liver meeting® 2021 marketscreener.com Sat, 12 Apr 2025 13:47:21 GMT
• cymabay therapeutics, inc. announces management changes marketscreener.com Sat, 05 Apr 2025 09:23:32 GMT
• cymabay halts development of seladelpar due to atypical histological findings in nash study FirstWord Pharma Sat, 01 Mar 2025 12:32:37 GMT
• report: developing opportunities within vereit, caredx, cymabay therapeutics, and harsco - future expectations, projections moving... ACCESS Newswire Wed, 26 Feb 2025 08:58:14 GMT
• primary biliary cholangitis market growth to accelerate in forecast period (2024-2034), delveinsight analyzes | intercept pharma, ... The Globe and Mail Thu, 10 Oct 2024 14:38:00 GMT
• why gilead sciences is buying cymabay therapeutics for $4.3 billion MSN Tue, 20 Aug 2024 08:51:34 GMT
• fda approves gilead's seladelpar for inflammatory liver disease, acquired via $4b cymabay deal MSN Sat, 17 Aug 2024 02:18:00 GMT
• Gilead’s $4.3B Bet on CymaBay Pays Off With FDA Nod for Autoimmune Liver Disease Drug BioSpace Thu, 15 Aug 2024 07:00:00 GMT
• fda approves gilead's seladelpar for inflammatory liver disease, acquired via $4b cymabay deal Yahoo Finance Thu, 15 Aug 2024 07:00:00 GMT
• Gilead gets US FDA approval for inflammatory liver disease drug Reuters Wed, 14 Aug 2024 07:00:00 GMT
• Gilead wins FDA accelerated approval of seladelpar after acquiring it in $4.3B deal Endpoints News Wed, 14 Aug 2024 07:00:00 GMT
• Gilead Liver Drug Wins FDA Approval, to Cost $12,606 a Month Bloomberg.com Wed, 14 Aug 2024 07:00:00 GMT
• fda grants accelerated approval to seladelpar (livdelzi) for primary biliary cholangitis MD Magazine Wed, 14 Aug 2024 07:00:00 GMT
• Gilead looks for FDA drug win this week, sealing a multibillion-dollar bet The Business Journals Mon, 12 Aug 2024 07:00:00 GMT
• On doorstep of FDA decision, Gilead pays J&J $320M to exit licensing deal for seladelpar Fierce Biotech Fri, 09 Aug 2024 07:00:00 GMT
• gilead shells out $320m to j&j to buy out rare liver disease drug royalties Endpoints News Thu, 08 Aug 2024 07:00:00 GMT
• 89bio appoints charles mcwherter, ph.d., to its board of directors StockTitan Mon, 05 Aug 2024 07:00:00 GMT
• dow surges over 150 points; gilead sciences to acquire cymabay therapeutics for $4.3b Quantisnow Mon, 01 Jul 2024 23:55:19 GMT
• cymabay therapeutics | biotechnology | the pharmaletter The Pharma Letter Sun, 30 Jun 2024 12:34:32 GMT
• here's why momentum in cymabay therapeutics inc. (cbay) should keep going Yahoo News Malaysia Sat, 29 Jun 2024 04:53:02 GMT
• institutional investors own a significant stake of 45% in cymabay therapeutics, inc. (nasdaq:cbay) Yahoo Movies Canada Sat, 29 Jun 2024 01:29:19 GMT
• nautic partners acquires surfaceprep in partnership with management World Business Outlook Fri, 28 Jun 2024 09:59:16 GMT
• cymabay appoints thomas wiggans and janet dorling to board of directors cymabay therapeutics, inc. Quantisnow Thu, 27 Jun 2024 20:58:22 GMT
• Gilead Sciences announces the acquisition of CymaBay Therapeutics World Business Outlook Wed, 26 Jun 2024 21:13:59 GMT
• oruka therapeutics announces key additions to leadership team and board of directors Yahoo Finance Wed, 26 Jun 2024 07:00:00 GMT
• institutional investors own a significant stake of 45% in cymabay therapeutics, inc. (nasdaq:cbay) Yahoo Movies Canada Tue, 25 Jun 2024 15:34:30 GMT
• gilead sciences announces the acquisition of cymabay therapeutics World Business Outlook Sun, 23 Jun 2024 07:24:47 GMT
• here's why momentum in cymabay therapeutics inc. (cbay) should keep going Yahoo News Malaysia Sat, 22 Jun 2024 14:09:28 GMT
• Gilead’s M&A appetite is for deals in the ‘mid-single-digit billions,’ CEO says Endpoints News Thu, 13 Jun 2024 07:00:00 GMT
• ipsen, genfit medicine is cleared by fda for rare liver disorder Bloomberg.com Mon, 10 Jun 2024 07:00:00 GMT
• gilead announces two-year interim results from assure study - tipranks.com TipRanks Thu, 06 Jun 2024 09:54:13 GMT
• Gilead, with approval in sight, shows $4.3B liver disease drug improves outcomes out to 2 years Fierce Biotech Wed, 05 Jun 2024 07:00:00 GMT
• gilead’s seladelpar demonstrated a sustained and consistent long-term efficacy and safety profile in primary biliary cholangitis Business Wire Wed, 05 Jun 2024 07:00:00 GMT
• gilead's seladelpar demonstrated a sustained and consistent long-term efficacy and safety profile in primary biliary ... Business Wire Wed, 05 Jun 2024 07:00:00 GMT
• cymabay therapeutics announces positive results from its phase 2b clinical study demonstrating that arhalofenate ... Yahoo Eurosport UK Wed, 29 May 2024 14:50:38 GMT
• cymabay therapeutics to present at upcoming conferences Yahoo News UK Wed, 22 May 2024 14:27:43 GMT
• Gilead's new liver disease med continues to deliver the goods ahead of FDA verdict Fierce Biotech Mon, 20 May 2024 07:00:00 GMT
• gilead liver disease med still delivers ahead of fda verdict Fierce Biotech Mon, 20 May 2024 07:00:00 GMT
• biopharmaceutical mergers and acquisitions surge to new highs The Economic Times Wed, 15 May 2024 07:00:00 GMT
• we think cymabay therapeutics (nasdaq:cbay) can afford to drive business growth Yahoo Canada Shine On Mon, 13 May 2024 10:46:55 GMT
• gilead posts quarterly loss on acquisition charge, revenue rises 5% MSN Sun, 12 May 2024 05:17:59 GMT
• cymabay (cbay) stock up on positive results from pbc study Yahoo Movies Canada Sat, 11 May 2024 11:00:21 GMT
• cymabay therapeutics inc. (cbay) just flashed golden cross signal: do you buy? Yahoo Canada Shine On Fri, 10 May 2024 03:39:06 GMT
• cymabay (cbay) stock up on positive results from pbc study Yahoo Movies Canada Mon, 06 May 2024 15:17:55 GMT
• cymabay therapeutics (nasdaq:cbay) coverage initiated by analysts at stocknews.com Defense World Sun, 05 May 2024 16:22:02 GMT
• gilead sciences: acquisition of cymabay therapeutics enhancing liver disease portfolio & 6 major drivers Smartkarma Sun, 05 May 2024 07:00:00 GMT
• is cymabay therapeutics (cbay) stock a solid choice right now? Yahoo New Zealand News Thu, 02 May 2024 17:00:40 GMT
• is swedish orphan biovitrum (biovf) stock outpacing its medical peers this year? Yahoo New Zealand News Wed, 01 May 2024 05:35:21 GMT
• gilead sciences: first-quarter results beat estimates The Motley Fool Mon, 29 Apr 2024 20:55:45 GMT
• cymabay therapeutics (nasdaq:cbay) coverage initiated at stocknews.com Defense World Sat, 27 Apr 2024 06:52:16 GMT
• gilead touts 5% revenue jump, positions for 2024 growth and culls pipeline BioSpace Fri, 26 Apr 2024 07:00:00 GMT
• gilead posts quarterly loss on acquisition charge, revenue rises 5% ETHealthWorld Fri, 26 Apr 2024 07:00:00 GMT
• gilead sales grow but swings to loss after cymabay buy The Pharma Letter Fri, 26 Apr 2024 07:00:00 GMT
• gilead posts quarterly loss, revenue rises 5% | the mighty 790 kfgo KFGO Thu, 25 Apr 2024 21:19:24 GMT
• gilead posts quarterly loss, revenue rises 5% SaltWire Halifax powered by The Chronicle Herald Thu, 25 Apr 2024 20:12:45 GMT
• Gilead Sciences Announces First Quarter 2024 Financial Results Business Wire Thu, 25 Apr 2024 07:00:00 GMT
• Gilead posts quarterly loss on acquisition charge, revenue rises 5% Reuters Thu, 25 Apr 2024 07:00:00 GMT
• gilead leans on cymabay liver drug, trodelvy readouts and long-active prep yet to come this year Endpoints News Thu, 25 Apr 2024 07:00:00 GMT
• cymabay therapeutics, inc. (nasdaq:cbay) shares purchased by raymond james & associates Defense World Sat, 20 Apr 2024 17:11:41 GMT
• cymabay's stock surges as gilead reaches $4.3 billion deal for liver-drug developer MSN Sat, 20 Apr 2024 10:22:42 GMT
• institutional investors own a significant stake of 50% in cymabay therapeutics, inc. (nasdaq:cbay) Yahoo Movies UK Fri, 19 Apr 2024 11:58:40 GMT
• cymabay therapeutics inc. (cbay) upgraded to buy: what does it mean for the stock? Yahoo Lifestyle UK Wed, 17 Apr 2024 16:09:46 GMT
• cymabay therapeutics inc. (cbay) upgraded to buy: what does it mean for the stock? Yahoo Lifestyle UK Sun, 14 Apr 2024 16:25:54 GMT
• cymabay therapeutics, inc. (nasdaq:cbay) receives consensus recommendation of “hold” from analysts Defense World Thu, 11 Apr 2024 07:05:18 GMT
• cymabay therapeutics (nasdaq:cbay) research coverage started at stocknews.com Defense World Thu, 11 Apr 2024 06:20:23 GMT
• cymabay therapeutics, inc. (nasdaq:cbay) shares bought by raymond james financial services advisors inc. Defense World Tue, 09 Apr 2024 08:43:45 GMT
• cymabay therapeutics, inc. (nasdaq:cbay) shares bought by vanguard group inc. Defense World Sat, 06 Apr 2024 08:21:34 GMT
• vanguard group inc. has $85.70 million position in cymabay therapeutics, inc. (nasdaq:cbay) MarketBeat Sat, 06 Apr 2024 08:18:01 GMT
• vanguard group inc. purchases 598,707 shares of cymabay therapeutics, inc. (nasdaq:cbay) MarketBeat Sat, 06 Apr 2024 08:18:01 GMT
• vanguard group inc. raises position in cymabay therapeutics, inc. (nasdaq:cbay) MarketBeat Sat, 06 Apr 2024 08:18:01 GMT
• how cymabay survived a safety scare - timmermanreport.com Timmerman Report Thu, 04 Apr 2024 07:00:00 GMT
• opthea bolsters board with biopharmaceutical expertise - tipranks.com TipRanks Thu, 04 Apr 2024 02:10:33 GMT
• fierce biotech's quarterly ipo and m&a roundup: q1'24 Fierce Biotech Wed, 03 Apr 2024 07:00:00 GMT
• cymabay therapeutics (nasdaq:cbay) earns sell rating from analysts at stocknews.com Defense World Wed, 03 Apr 2024 07:00:00 GMT
• cymabay therapeutics (nasdaq:cbay) receives new coverage from analysts at stocknews.com MarketBeat Wed, 03 Apr 2024 06:16:27 GMT
• cymabay therapeutics (nasdaq:cbay) coverage initiated at stocknews.com MarketBeat Wed, 03 Apr 2024 06:16:27 GMT
• cymabay therapeutics (nasdaq:cbay) research coverage started at stocknews.com MarketBeat Wed, 03 Apr 2024 06:16:27 GMT
• cymabay therapeutics appoints robert j. wills, ph.d. to board of directors Yahoo Singapore News Tue, 02 Apr 2024 19:03:23 GMT
• cymabay therapeutics inc. (cbay) just flashed golden cross signal: do you buy? Yahoo Movies UK Tue, 02 Apr 2024 16:20:05 GMT
• assenagon asset management s.a. acquires new stake in cymabay therapeutics, inc. (nasdaq:cbay) MarketBeat Fri, 29 Mar 2024 04:44:41 GMT
• assenagon asset management s.a. buys shares of 746,353 cymabay therapeutics, inc. (nasdaq:cbay) MarketBeat Thu, 28 Mar 2024 23:03:45 GMT
• assenagon asset management s.a. acquires new stake in cymabay therapeutics, inc. (nasdaq:cbay) MarketBeat Thu, 28 Mar 2024 20:37:30 GMT
• assenagon asset management s.a. makes new $17.63 million investment in cymabay therapeutics, inc. (nasdaq ... MarketBeat Thu, 28 Mar 2024 16:52:30 GMT
• assenagon asset management s.a. purchases new position in cymabay therapeutics, inc. (nasdaq:cbay) Defense World Thu, 28 Mar 2024 10:02:15 GMT
• assenagon asset management s.a. invests $17.63 million in cymabay therapeutics, inc. (nasdaq:cbay) MarketBeat Thu, 28 Mar 2024 09:59:05 GMT
• citigroup inc. cuts stock position in cymabay therapeutics, inc. (nasdaq:cbay) Defense World Wed, 27 Mar 2024 08:36:00 GMT
• Tvardi Therapeutics Appoints Sujal Shah as Chairman and Adds Shaheen Wirk to the Board of Directors Business Wire Tue, 26 Mar 2024 07:00:00 GMT
• stocknews.com initiates coverage on cymabay therapeutics (nasdaq:cbay) MarketBeat Tue, 26 Mar 2024 02:58:53 GMT
• stocknews.com begins coverage on cymabay therapeutics (nasdaq:cbay) MarketBeat Mon, 25 Mar 2024 21:02:24 GMT
• Gilead concludes acquisition of CymaBay Therapeutics for $4.3bn Pharmaceutical Technology Mon, 25 Mar 2024 07:00:00 GMT
• Cirrhosis Clinical Trial Pipeline Insights Featuring 45+ Companies | DelveInsight GlobeNewswire Mon, 25 Mar 2024 07:00:00 GMT
• gilead sciences completes acquisition of cymabay, for approximately $4.3 billion FinSMEs Mon, 25 Mar 2024 07:00:00 GMT
• gilead sciences completes deal to buy cymabay for $4.3 billion Pulse 2.0 Mon, 25 Mar 2024 07:00:00 GMT
• cymabay therapeutics (nasdaq:cbay) coverage initiated by analysts at stocknews.com Defense World Mon, 25 Mar 2024 06:23:53 GMT
• stocknews.com initiates coverage on cymabay therapeutics (nasdaq:cbay) MarketBeat Mon, 25 Mar 2024 06:20:20 GMT
• gilead sciences completes acquisition of cymabay therapeutics for usd 4.3 billion Medical Dialogues Sun, 24 Mar 2024 07:00:00 GMT
• gilead completes cymabay acquisition but negative impact on 2024 eps MSN Sat, 23 Mar 2024 14:39:24 GMT
• gilead says cymabay deal to lower 2024 eps by $3.35-$3.45 - tipranks.com TipRanks Sat, 23 Mar 2024 13:34:03 GMT
• cymabay therapeutics: major acquisition and leadership overhaul - tipranks.com TipRanks Sat, 23 Mar 2024 07:43:55 GMT
• gilead reduces 2024 earnings guidance after completing cymabay takeover by investing.com Investing.com Australia Sat, 23 Mar 2024 07:00:00 GMT
• deutsche bank ag sells 369,851 shares of cymabay therapeutics, inc. (nasdaq:cbay) MarketBeat Sat, 23 Mar 2024 00:12:08 GMT
• deutsche bank ag has $6.80 million stock position in cymabay therapeutics, inc. (nasdaq:cbay) MarketBeat Fri, 22 Mar 2024 19:17:07 GMT
• deutsche bank ag trims stake in cymabay therapeutics, inc. (nasdaq:cbay) Defense World Fri, 22 Mar 2024 08:47:49 GMT
• deutsche bank ag sells 369,851 shares of cymabay therapeutics, inc. (nasdaq:cbay) MarketBeat Fri, 22 Mar 2024 08:18:23 GMT
• cymabay therapeutics, inc. (nasdaq:cbay) shares sold by deutsche bank ag MarketBeat Fri, 22 Mar 2024 08:18:23 GMT
• Gilead Sciences Announces Completion of Acquisition of CymaBay Business Wire Fri, 22 Mar 2024 07:00:00 GMT
• Gilead Sciences Completes Acquisition Of CymaBay Therapeutics Nasdaq Fri, 22 Mar 2024 07:00:00 GMT
• cymabay therapeutics: major acquisition and leadership overhaul TipRanks Fri, 22 Mar 2024 07:00:00 GMT
• cymabay therapeutics, inc. announces board changes Marketscreener.com Fri, 22 Mar 2024 07:00:00 GMT
• gilead sciences bolsters portfolio with cymabay acquisition TipRanks Fri, 22 Mar 2024 07:00:00 GMT
• gilead (gild) reduces 2024 earnings guidance after completing cymabay takeover StreetInsider.com Fri, 22 Mar 2024 07:00:00 GMT
• gilead finalizes cymabay acquisition to bolster liver disease treatments by investing.com Investing.com Nigeria Fri, 22 Mar 2024 07:00:00 GMT
• gilead completes cymabay acquisition but negative impact on 2024 eps (nasdaq:gild) Seeking Alpha Fri, 22 Mar 2024 07:00:00 GMT
• gilead reduces 2024 earnings guidance after completing cymabay takeover by investing.com Investing.com Fri, 22 Mar 2024 07:00:00 GMT
• gilead says cymabay deal to lower 2024 eps by $3.35-$3.45 - tipranks.com TipRanks Fri, 22 Mar 2024 07:00:00 GMT
• cymabay therapeutics revamps executive compensation agreements TipRanks Wed, 20 Mar 2024 20:33:38 GMT
• cymabay therapeutics (nasdaq:cbay) hits new 12-month high at $32.48 MarketBeat Mon, 18 Mar 2024 18:56:15 GMT
• cymabay therapeutics (nasdaq:cbay) reaches new 52-week high at $32.48 MarketBeat Mon, 18 Mar 2024 14:58:24 GMT
• cymabay therapeutics (nasdaq:cbay) sets new 52-week high at $32.48 MarketBeat Mon, 18 Mar 2024 14:58:21 GMT
• hudson bay capital management lp acquires shares of 30000 cymabay therapeutics, inc. (nasdaq:cbay) Defense World Mon, 18 Mar 2024 09:10:38 GMT
• cymabay therapeutics, inc. (nasdaq:cbay) given consensus rating of "hold" by analysts MarketBeat Mon, 18 Mar 2024 03:59:31 GMT
• cymabay therapeutics (nasdaq:cbay) coverage initiated by analysts at stocknews.com MarketBeat Mon, 18 Mar 2024 02:59:00 GMT
• cymabay therapeutics, inc. (nasdaq:cbay) given consensus rating of "hold" by analysts MarketBeat Sun, 17 Mar 2024 07:01:03 GMT
• brokerages set cymabay therapeutics, inc. (nasdaq:cbay) pt at $28.65 MarketBeat Sun, 17 Mar 2024 07:01:03 GMT
• cymabay therapeutics, inc. (nasdaq:cbay) given average rating of "hold" by analysts MarketBeat Sun, 17 Mar 2024 07:01:03 GMT
• cymabay therapeutics, inc. (nasdaq:cbay) receives consensus rating of “hold” from brokerages Defense World Sun, 17 Mar 2024 06:59:30 GMT
• cymabay therapeutics (nasdaq:cbay) coverage initiated by analysts at stocknews.com MarketBeat Sun, 17 Mar 2024 06:20:55 GMT
• cymabay therapeutics (nasdaq:cbay) earns sell rating from analysts at stocknews.com MarketBeat Sun, 17 Mar 2024 06:20:55 GMT
• stocknews.com begins coverage on cymabay therapeutics (nasdaq:cbay) Defense World Sun, 17 Mar 2024 06:19:03 GMT
• cymabay therapeutics, inc. (nasdaq:cbay) sees significant drop in short interest MarketBeat Thu, 14 Mar 2024 23:57:28 GMT
• cymabay therapeutics (nasdaq:cbay) sets new 1-year high at $32.43 Defense World Wed, 13 Mar 2024 08:56:37 GMT
• cymabay therapeutics (nasdaq:cbay) reaches new 1-year high at $32.43 MarketBeat Mon, 11 Mar 2024 13:21:02 GMT
• investing in cymabay therapeutics (nasdaq:cbay) three years ago would have delivered you a 540% gain Yahoo Finance Mon, 11 Mar 2024 07:00:00 GMT
• gilead, cymabay therapeutics receive us antitrust clearance for their deal MLex Mon, 11 Mar 2024 07:00:00 GMT
• gilead sciences announces expiration of hart-scott-rodino waiting period for cymabay tender offer Yahoo Finance Mon, 11 Mar 2024 07:00:00 GMT
• gilead advances in cymabay acquisition with antitrust clearance Investing.com Mon, 11 Mar 2024 07:00:00 GMT
• glenmede trust co. na takes position in cymabay therapeutics, inc. (nasdaq:cbay) Defense World Mon, 11 Mar 2024 04:33:14 GMT
• glenmede trust co. na buys shares of 37,894 cymabay therapeutics, inc. (nasdaq:cbay) MarketBeat Sun, 10 Mar 2024 14:30:20 GMT
• 40462 shares in cymabay therapeutics, inc. (nasdaq:cbay) purchased by gotham asset management llc Defense World Sun, 10 Mar 2024 09:47:31 GMT
• gotham asset management llc purchases shares of 40,462 cymabay therapeutics, inc. (nasdaq:cbay) MarketBeat Sun, 10 Mar 2024 09:42:32 GMT
• recent price trend in cymabay therapeutics inc. (cbay) is your friend, here's why Yahoo Lifestyle UK Sun, 10 Mar 2024 09:07:12 GMT
• seven eight capital lp purchases shares of 41,556 cymabay therapeutics, inc. (nasdaq:cbay) MarketBeat Sat, 09 Mar 2024 12:02:51 GMT
• cymabay therapeutics (nasdaq:cbay) coverage initiated by analysts at stocknews.com Defense World Sat, 09 Mar 2024 07:26:10 GMT
• rhumbline advisers has $1.93 million stake in cymabay therapeutics, inc. (nasdaq:cbay) Defense World Thu, 07 Mar 2024 09:25:29 GMT
• cymabay therapeutics, inc. (nasdaq:cbay) position lessened by adage capital partners gp l.l.c. MarketBeat Wed, 06 Mar 2024 07:38:42 GMT
• cymabay therapeutics inc. revenue breakdown – swb:c0i – tradingview TradingView Wed, 06 Mar 2024 05:21:44 GMT
• invesco ltd. acquires 19789 shares of cymabay therapeutics, inc. (nasdaq:cbay) Defense World Tue, 05 Mar 2024 12:40:55 GMT
• fmr llc increases stock holdings in cymabay therapeutics, inc. (nasdaq:cbay) Defense World Tue, 05 Mar 2024 11:04:16 GMT
• cymabay announces european medicine accepts for review the maa for seladelpar - tipranks.com TipRanks Mon, 04 Mar 2024 12:56:15 GMT
• CymaBay Announces European Medicines Agency Accepts for GlobeNewswire Mon, 04 Mar 2024 08:00:00 GMT
• brief—ema accepts maa for seladelpar for the treatment of primary biliary cholangitis The Pharma Letter Mon, 04 Mar 2024 08:00:00 GMT
• cymabay seeks ema nod for liver disease drug seladelpar by investing.com Investing.com Mon, 04 Mar 2024 08:00:00 GMT
• cymabay therapeutics, inc. to post q1 2024 earnings of ($0.23) per share, hc wainwright forecasts (nasdaq:cbay) MarketBeat Mon, 04 Mar 2024 07:09:59 GMT
• william blair weighs in on cymabay therapeutics, inc.'s q1 2024 earnings (nasdaq:cbay) Defense World Mon, 04 Mar 2024 07:09:27 GMT
• q1 2024 earnings forecast for cymabay therapeutics, inc. (nasdaq:cbay) issued by hc wainwright Defense World Mon, 04 Mar 2024 07:09:06 GMT
• cymabay therapeutics (nasdaq:cbay) sets new 1-year high at $32.35 MarketBeat Sat, 02 Mar 2024 15:38:15 GMT
• fy2028 earnings estimate for cymabay therapeutics, inc. (nasdaq:cbay) issued by hc wainwright AmericanBankingNEWS Sat, 02 Mar 2024 09:43:26 GMT
• hc wainwright equities analysts lower earnings estimates for cymabay therapeutics, inc. (nasdaq:cbay) MarketBeat Fri, 01 Mar 2024 13:50:14 GMT
• 610,770 shares in cymabay therapeutics, inc. (nasdaq:cbay) acquired by mpm bioimpact llc MarketBeat Fri, 01 Mar 2024 11:49:48 GMT
• trexquant investment lp acquires 163,278 shares of cymabay therapeutics, inc. (nasdaq:cbay) MarketBeat Fri, 01 Mar 2024 11:49:48 GMT
• cymabay reports fourth quarter and year ended december 31, 2021 financial results and provides corporate update The Globe and Mail Fri, 01 Mar 2024 09:00:00 GMT
• CymaBay Investor Alleges Gilead Buyout Filing Omits Conflicts Bloomberg Law News Fri, 01 Mar 2024 08:00:00 GMT
• stocknews.com initiates coverage on cymabay therapeutics (nasdaq:cbay) AmericanBankingNEWS Fri, 01 Mar 2024 07:49:10 GMT
• analyzing cymabay therapeutics (nasdaq:cbay) and nature's sunshine products (nasdaq:natr) AmericanBankingNEWS Fri, 01 Mar 2024 06:53:56 GMT
• a new cause for concern: cymabay therapeutics inc adds a new corporate activity and growth risk TipRanks Fri, 01 Mar 2024 06:03:21 GMT
• cymabay therapeutics (nasdaq:cbay) rating reiterated by hc wainwright MarketBeat Fri, 01 Mar 2024 00:56:13 GMT
• trading (cbay) with integrated risk controls Stock Traders Daily.com Thu, 29 Feb 2024 21:42:00 GMT
• cymabay therapeutics (nasdaq:cbay) rating reiterated by hc wainwright MarketBeat Thu, 29 Feb 2024 14:34:54 GMT
• a new cause for concern: cymabay therapeutics inc adds a new corporate activity and growth risk TipRanks Thu, 29 Feb 2024 08:00:00 GMT
• brodsky & smith shareholder update: notifying investors of the following investigations: cymabay ... GlobeNewswire Thu, 29 Feb 2024 08:00:00 GMT
• cymabay therapeutics inc. (cbay) reports q4 loss, misses revenue estimates Zacks Investment Research Thu, 29 Feb 2024 00:35:28 GMT
• algert global llc purchases new shares in cymabay therapeutics, inc. (nasdaq:cbay) MarketBeat Wed, 28 Feb 2024 22:29:52 GMT
• rafferty asset management llc takes position in cymabay therapeutics, inc. (nasdaq:cbay) AmericanBankingNEWS Wed, 28 Feb 2024 11:10:53 GMT
• cymabay therapeutics inc. (cbay) reports q4 loss, misses revenue estimates Yahoo Finance Wed, 28 Feb 2024 08:00:00 GMT
• cymabay reports fourth quarter and year ended december 31, GlobeNewswire Wed, 28 Feb 2024 08:00:00 GMT
• gilead sciences to buy cymabay therapeutics for $4.3 billion Barron's Wed, 28 Feb 2024 01:42:17 GMT
• Gilead bid against itself in $4.3B deal for CymaBay, filing shows Endpoints News Mon, 26 Feb 2024 08:00:00 GMT
• CymaBay board pushed for 50 cent top up to Gilead's $32.50 per share offer Fierce Biotech Mon, 26 Feb 2024 08:00:00 GMT
• Gilead Sciences Acquires CymaBay Therapeutics for $4.3 Billion, Expanding Portfolio Beyond HIV Drugs The Healthcare Technology Report. Mon, 26 Feb 2024 08:00:00 GMT
• cymabay's seladelpar has the potential to raise the bar in treatment for pbc OutSourcing-Pharma.com Mon, 26 Feb 2024 08:00:00 GMT
• genuinely exciting phase 3 results for cymabay's seladelpar OutSourcing-Pharma.com Mon, 26 Feb 2024 08:00:00 GMT
• monashee investment management llc acquires new shares in cymabay therapeutics, inc. (nasdaq:cbay) MarketBeat Sun, 25 Feb 2024 21:08:00 GMT
• omers administration corp buys shares of 24900 cymabay therapeutics, inc. (nasdaq:cbay) MarketBeat Sun, 25 Feb 2024 14:41:19 GMT
• cymabay therapeutics (nasdaq:cbay) sets new 52-week high at $32.25 Defense World Sun, 25 Feb 2024 07:01:17 GMT
• cymabay therapeutics (nasdaq:cbay) reaches new 12-month high at $32.25 MarketBeat Sat, 24 Feb 2024 16:06:11 GMT
• cymabay therapeutics, inc. (nasdaq:cbay) shares purchased by swiss national bank MarketBeat Fri, 23 Feb 2024 09:27:07 GMT
• Gilead bumped up price for liver drug maker by $9.50 but wouldn't budge on another 50 cents The Business Journals Fri, 23 Feb 2024 08:00:00 GMT
• cymabay therapeutics, inc. (nasdaq:cbay) stake lessened by deutsche bank ag MarketBeat Thu, 22 Feb 2024 10:28:51 GMT
• cymabay therapeutics (nasdaq:cbay) earns sell rating from analysts at stocknews.com MarketBeat Thu, 22 Feb 2024 07:18:41 GMT
• A Phase 3 Trial of Seladelpar in Primary Biliary Cholangitis The New England Journal of Medicine Wed, 21 Feb 2024 08:00:00 GMT
• The New England Journal of Medicine Publishes Positive Phase 3 RESPONSE Data of CymaBay's Seladelpar in Primary Biliary Cholangiti... PR Newswire Wed, 21 Feb 2024 08:00:00 GMT
• trimble, cymabay therapy rise; big lots, monday.com fall, monday, 2/12/2024 ABC News Wed, 21 Feb 2024 08:00:00 GMT
• cymabay therapeutics, inc. (nasdaq:cbay) receives average rating of “hold” from analysts Defense World Wed, 21 Feb 2024 06:41:45 GMT
• cymabay therapeutics, inc. (nasdaq:cbay) given average rating of "hold" by brokerages MarketBeat Wed, 21 Feb 2024 06:41:10 GMT
• clarivest asset management llc sells 63600 shares of cymabay therapeutics, inc. (nasdaq:cbay) MarketBeat Tue, 20 Feb 2024 15:21:01 GMT
• leerink cuts cymabay stock rating post gilead acquisition news by investing.com Investing.com Tue, 20 Feb 2024 14:16:00 GMT
• svb leerink reaffirms market perform rating for cymabay therapeutics (nasdaq:cbay) MarketBeat Tue, 20 Feb 2024 13:24:19 GMT
• opinion: 2024 will be a buyers’ market in biopharma. it already is. BioSpace Tue, 20 Feb 2024 08:00:00 GMT
• cymabay announces inducement grants under nasdaq listing rule 5635(c)(4) GlobeNewswire Tue, 20 Feb 2024 08:00:00 GMT
• gilead sciences embarks on global expansion with oxford research hub and cymabay acquisition BNN Breaking Mon, 19 Feb 2024 11:10:38 GMT
• gilead sciences expands oncology footprint with saudi partnership and acquires cymabay in a $4.3 billion deal BNN Breaking Mon, 19 Feb 2024 09:13:54 GMT
• cymabay therapeutics, inc. (nasdaq:cbay) shares acquired by new york state common retirement fund MarketBeat Sun, 18 Feb 2024 09:32:10 GMT
• gilead sciences acquires cymabay therapeutics for $4.3 billion: a game-changer in liver disease treatment Medriva Sat, 17 Feb 2024 14:43:00 GMT
• gilead sciences acquires cymabay therapeutics: a strategic move in the healthcare industry Medriva Sat, 17 Feb 2024 08:00:00 GMT
• cymabay therapeutics investor alert by the former attorney general of louisiana: kahn swick & foti, llc ... Business Wire Fri, 16 Feb 2024 08:00:00 GMT
• fy2026 earnings forecast for cymabay therapeutics, inc. (nasdaq:cbay) issued by hc wainwright MarketBeat Fri, 16 Feb 2024 00:34:11 GMT
• biotech alert: searches spiking for these stocks today - tipranks.com TipRanks Thu, 15 Feb 2024 16:10:45 GMT
• cymabay therapeutics, inc. (nasdaq:cbay) expected to post fy2024 earnings of ($1.20) per share MarketBeat Thu, 15 Feb 2024 13:34:42 GMT
• gilead sciences acquires cymabay for $4.3 billion, heralding a new era in pbc treatment geneonline Thu, 15 Feb 2024 10:17:57 GMT
• Gilead Announced Plans to Acquire CymaBay in a $4.3 Billion Deal TechTarget Thu, 15 Feb 2024 08:00:00 GMT
• friday five – gilead shifts gears, leqembi’s lacklustre showing, pancreatic cancer breakthrough…and more FirstWord Pharma Thu, 15 Feb 2024 08:00:00 GMT
• director janet dorling sells 6,000 shares of cymabay therapeutics inc (cbay) Yahoo Finance Thu, 15 Feb 2024 08:00:00 GMT
• biotech stock roundup: biib's q4 results, cbay up on gild's acquisition & other updates Yahoo Finance Thu, 15 Feb 2024 08:00:00 GMT
• cymabay therapeutics, inc. (nasdaq:cbay) analysts just slashed next year's revenue estimates by 17% Simply Wall St Thu, 15 Feb 2024 08:00:00 GMT
• analysts offer predictions for cymabay therapeutics, inc.'s fy2028 earnings (nasdaq:cbay) MarketBeat Wed, 14 Feb 2024 13:49:29 GMT
• cymabay therapeutics (nasdaq:cbay) earns market perform rating from lifesci capital MarketBeat Wed, 14 Feb 2024 13:29:31 GMT
• Gilead expands liver disease pipeline with $4.3bn CymaBay acquisition PMLiVE Wed, 14 Feb 2024 08:00:00 GMT
• gilead plans $4.3 billion deal to advance liver portfolio European Pharmaceutical Review Wed, 14 Feb 2024 08:00:00 GMT
CymaBay Therapeutics, Inc(NASDAQ:CBAY) 
CymaBay Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing and providing therapies to treat liver and other chronic diseases. Its lead product candidate is seladelpar (MBX-8025), a selective agonist of peroxisome proliferator activated receptor delta, which has com...
Website: http://www.cymabay.com
Founded: 1988
Full Time Employees: 36
Sector: Healthcare
Industry: Biotechnology